A Randomized Prospective Trial of Oral Versus Intravenous Ganciclovir for Prophylaxis of Cytomegalovirus Infection and Disease in High-Risk Kidney Recipients

The Impact of Cytomegalovirus Infection and Disease on Rejection Episodes in Renal Allograft Recipients

Solbjørg Sagedal, Knut P. Nordal, Anders Hartmann et al. · American Journal of Transplantation · 2002 · 291 citations · Full text

Medicine, Infectious Diseases, Nephrology +17

PROPHYLACTIC ORAL GANCICLOVIR COMPARED WITH DEFERRED THERAPY FOR CONTROL OF CYTOMEGALOVIRUS IN RENAL TRANSPLANT RECIPIENTS1,2,???

Daniel C. Brennan, Kathy A. Garlock, Gary G. Singer et al. · Transplantation · 1997 · 157 citations

Medicine, Infectious Diseases, Nephrology +17

ASSOCIATION BETWEEN CYTOMEGALOVIRUS DISEASE AND CHRONIC REJECTION IN KIDNEY TRANSPLANT RECIPIENTS1

Abhinav Humar, Kristen J. Gillingham, William D. Payne et al. · Transplantation · 1999 · 147 citations

Medicine, Nephrology, Surgery +14

A RANDOMIZED PROSPECTIVE CONTROLLED TRIAL OF ORAL ACYCLOVIR VERSUS ORAL GANCICLOVIR FOR CYTOMEGALOVIRUS PROPHYLAXIS IN HIGH-RISK KIDNEY TRANSPLANT RECIPIENTS1

Stuart M. Flechner, Robin K. Avery, Rosemaree Fisher et al. · Transplantation · 1998 · 137 citations

Medicine, Immunology, Infectious Diseases +15

LONG-TERM ORAL GANCICLOVIR PROPHYLAXIS FOR PREVENTION OF CYTOMEGALOVIRUS INFECTION AND DISEASE IN CYTOMEGALOVIRUS HIGH-RISK RENAL TRANSPLANT RECIPIENTS

Josef Kletzmayr, Evelyn Kreuzwieser, Thomas Watkins‐Riedel et al. · Transplantation · 2000 · 49 citations

Medicine, Infectious Diseases, Nephrology +16